Due to JD.com's profitability significantly exceeding market expectations, various major investment banks have expressed optimism. Citibank noted that JD.com's second-quarter profit was significantly above expectations, and believes that if the old-for-new policy progresses faster than anticipated, it will further boost the company's stock price. Guosen Securities continues to maintain its "Outperform" rating; China International Capital Corporation mentioned in its research report that, given the better-than-expected improvement in JD Logistics' profit margin, it maintains an "Outperform" rating; BOC International upgraded JD Logistics' rating to "Buy," considering its current valuation to be below the industry average; Huatai Securities also maintains a "Buy" rating for JD Health, expecting its profits to grow steadily in 2024.
